Cargando…
Boosting proteolytic pathways as a treatment against glycation-derived damage in the brain?
Autores principales: | Taylor, Allen, Bejarano, Eloy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463977/ https://www.ncbi.nlm.nih.gov/pubmed/34269200 http://dx.doi.org/10.4103/1673-5374.317971 |
Ejemplares similares
-
Autophagic receptor p62 protects against glycation‐derived toxicity and enhances viability
por: Aragonès, Gemma, et al.
Publicado: (2020) -
Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches
por: Gioia, Magda, et al.
Publicado: (2020) -
Metformin and the ATM DNA damage response (DDR): Accelerating the onset of stress-induced senescence to boost protection against cancer
por: Menendez, Javier A., et al.
Publicado: (2011) -
Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors
por: Ennes-Vidal, Vítor, et al.
Publicado: (2022) -
Autophagy and Glycative Stress: A Bittersweet Relationship in Neurodegeneration
por: Gómez, Olga, et al.
Publicado: (2021)